TrialPloS one2015

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.

Graeme J Moyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.